A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis
Public ClinicalTrials.gov record NCT02778399. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Phase 2b Dose-ranging Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis Associated Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the efficacy and safety of a range of oral doses of OBE2109 versus placebo, in reducing endometriosis associated pain.
Study identification
- NCT ID
- NCT02778399
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 328 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2016 (Actual)
- Primary completion
- Apr 2018 (Actual)
- Completion
- Jul 1, 2019 (Actual)
- Last update posted
- Jul 21, 2022
2016 – 2019
United States locations
- U.S. sites
- 71
- U.S. states
- 24
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site reference ID 455 | Chandler | Arizona | — | — |
| Site reference ID 439 | Scottsdale | Arizona | — | — |
| Site reference ID 462 | Arcadia | California | — | — |
| Site reference ID 405 | Chino | California | — | — |
| Site reference ID 463 | Huntington Park | California | — | — |
| Site refenrec ID 469 | Northridge | California | — | — |
| Site reference ID 431 | San Diego | California | — | — |
| Site reference ID 440 | Tustin | California | — | — |
| Site reference ID 474 | Denver | Colorado | — | — |
| Site reference ID 450 | Lakewood | Colorado | — | — |
| Site reference ID 425 | Longmont | Colorado | — | — |
| Site reference ID 410 | Washington D.C. | District of Columbia | — | — |
| Site reference ID 457 | Boca Raton | Florida | — | — |
| Site reference ID 418 | Clearwater | Florida | — | — |
| Site reference ID 437 | Gainesville | Florida | — | — |
| Site reference ID 458 | Jensen Beach | Florida | — | — |
| Site reference ID 411 | Miami | Florida | — | — |
| Site reference ID 424 | Miami | Florida | — | — |
| Site reference ID 435 | Miami | Florida | — | — |
| Site reference ID 420 | Miami Lakes | Florida | — | — |
| Site reference ID 441 | Miami Springs | Florida | — | — |
| Site reference ID 423 | New Port Richey | Florida | — | — |
| Site reference ID 426 | Tampa | Florida | — | — |
| Site reference ID 442 | Wellington | Florida | — | — |
| Site reference ID 428 | Atlanta | Georgia | — | — |
| Site reference ID 459 | Atlanta | Georgia | — | — |
| Site reference ID 475 | Nampa | Idaho | — | — |
| Site reference ID 465 | Oak Brook | Illinois | — | — |
| Site reference ID 404 | Shawnee Mission | Kansas | — | — |
| Site reference ID 456 | Wichita | Kansas | — | — |
| Site reference ID 454 | Marrero | Louisiana | — | — |
| Site reference ID 453 | Metairie | Louisiana | — | — |
| Site reference ID 478 | Glen Burnie | Maryland | — | — |
| Site reference ID 445 | Fall River | Massachusetts | — | — |
| Site reference ID 471 | Fall River | Massachusetts | — | — |
| Site reference ID 430 | Ann Arbor | Michigan | — | — |
| Site reference ID 409 | Bay City | Michigan | — | — |
| Site reference ID 468 | Saginaw | Michigan | — | — |
| Site reference ID 473 | Saginaw | Michigan | — | — |
| Site reference ID 427 | Southfield | Michigan | — | — |
| Site reference ID 421 | Albuquerque | New Mexico | — | — |
| Site reference ID 466 | New York | New York | — | — |
| Site reference ID 436 | Greensboro | North Carolina | — | — |
| Site reference ID 433 | Morehead City | North Carolina | — | — |
| Site reference ID 443 | Dayton | Ohio | — | — |
| Site reference ID 472 | Franklin | Ohio | — | — |
| Site reference ID 415 | Tiffin | Ohio | — | — |
| Site reference ID 414 | Westerville | Ohio | — | — |
| Site reference ID 419 | Bryn Mawr | Pennsylvania | — | — |
| Site reference ID 449 | Jenkintown | Pennsylvania | — | — |
| Site reference ID 476 | Columbia | South Carolina | — | — |
| Site reference ID 408 | Bristol | Tennessee | — | — |
| Site reference ID 403 | Chattanooga | Tennessee | — | — |
| Site reference ID 429 | Nashville | Tennessee | — | — |
| Site reference ID 452 | Austin | Texas | — | — |
| Site reference ID 461 | Beaumont | Texas | — | — |
| Site reference ID 447 | Dallas | Texas | — | — |
| Site reference ID 460 | Dallas | Texas | — | — |
| Site reference ID 464 | Fort Worth | Texas | — | — |
| Site reference ID 413 | Houston | Texas | — | — |
| Site reference ID 434 | Houston | Texas | — | — |
| Site reference ID 479 | Houston | Texas | — | — |
| Site reference ID 451 | San Antonio | Texas | — | — |
| Site reference ID 402 | Schertz | Texas | — | — |
| Site reference ID 432 | Webster | Texas | — | — |
| Site reference ID 422 | Draper | Utah | — | — |
| Site reference ID 467 | Centreville | Virginia | — | — |
| Site reference ID 407 | Norfolk | Virginia | — | — |
| Site reference ID 412 | Richmond | Virginia | — | — |
| Site reference ID 417 | Richmond | Virginia | — | — |
| Site reference ID 406 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02778399, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02778399 live on ClinicalTrials.gov.